Table 1.
Participant demographics.
| Healthy aging | Mild cognitive impairment | Mild to moderate AD | ANOVA p-value | |
|---|---|---|---|---|
| Male:Female | 3:12 | 8:9 | 2:9 | 0.24 |
| Age | 74.7 (5.2) | 74.3 (7.7) | 78.4 (8.6) | 0.12 |
| CDR | 0 | 0.48 (0.2) | 0.6 (0.2) | |
| MMSE | 29.4 (1) | 27.8 (1.7) | 22 (1.6) | |
| APOE Not tested | 15 | 3 | 0 | |
| APOE ε2ε2 | 0 | 0 | ||
| APOE ε2ε3 | 1 | 0 | ||
| APOE ε3ε3 | 6 | 4 | ||
| APOE ε2ε4 | 0 | 0 | ||
| APOE ε3ε4 | 5 | 5 | ||
| APOE ε4ε4 | 2 | 2 |
Mean values are given for male to female ratios, age in years, CDR and MMSE values as well as APOE status for all participants. Standard deviations are noted in brackets and p values on the right show non-significant differences between groups. Abbreviations: AD, Alzheimer’s Disease; CDR, Clinical Dementia Rating; MMSE, Mini-Mental State Examination; APOE, Apolipoprotein E.